Targeting the viral‐entry facilitators of SARS‐CoV‐2 as a therapeutic strategy in COVID‐19
Author:
Affiliation:
1. Biopharmaceutical Research Lab, Anusandhan Kendra‐1 SASTRA Deemed‐to‐be‐University Thanjavur Tamil Nadu India
2. School of Chemical and Biotechnology SASTRA Deemed‐to‐be‐University Thanjavur Tamil Nadu India
Publisher
Wiley
Subject
Infectious Diseases,Virology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27019
Reference109 articles.
1. World Health Organization. (WHO). Novel Coronavirus (2019‐nCoV) Situation Report—1 21 January 2020.WHO Bull.2020;(January):1‐7.
2. World Health Organization. COVID‐19 Weekly Epidemiological Update 22. World Health Organization.2020;(December):1‐3.https://www.who.int/docs/default-source/coronaviruse/situation-reports/weekly_epidemiological_update_22.pdf
3. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2
4. A pneumonia outbreak associated with a new coronavirus of probable bat origin
5. Structural basis for the recognition of SARS‐CoV‐2 by full‐length human ACE2;Wu C;Science (80‐),2020
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants;Scientific Reports;2024-02-02
2. The Potential of Anti-coronavirus Plant Secondary Metabolites in COVID-19 Drug Discovery as an Alternative to Repurposed Drugs: A Review;Planta Medica;2023-11-13
3. Conventional Understanding of SARS‐CoV‐2 Mpro and Common Strategies for Developing Its Inhibitors;ChemBioChem;2023-10-18
4. Hyperglycemia-induced cathepsin L maturation: Implications for diabetic comorbidities and COVID-19 susceptibility;2023-10-15
5. Cathepsins and SARS‐CoV‐2 infection: From pathogenic factors to potential therapeutic targets;British Journal of Pharmacology;2023-08-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3